MarketPeel
Insider Trading Intelligence
Pricing
…
PR

Paul D. Rubin

BIOA
CHIEF MEDICAL OFFICER · BIOAGE LABS, INC. · CIK 0001210905
FILING MIX · LIFETIME43%/57%
BUYS
12
SELLS
16
TOTAL VALUE
$2.01M
COMPANIES
1
ACTIVE SINCE
Feb 2025
HOLDINGS NOW
8,820
AVG SELL PX
$12.38
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Paul D. Rubin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+16.67%+4.86%+0.58%+4.29%+3.30%—
14d6+50.00%+12.87%+0.55%+12.32%+5.30%—
30d6+33.33%+12.58%+1.09%+11.49%+10.39%—
60d6+50.00%+30.79%+0.32%+37.12%+59.89%—
90d6+33.33%+33.76%+2.35%+42.23%+40.40%—
180d6(3 pending)+0.00%+62.30%+8.64%+52.87%+52.87%—
1y6(6 pending)——————
2y6(6 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BIOA · 8,820 shares · as of Apr 1, 2026
050,000100,000150,000200,0002026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 16 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
3,383——0Apr 1, 2026Apr 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
8,820$17.81$157.1K0Apr 1, 2026Apr 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
5,437$4.11$22.3K5,437Apr 1, 2026Apr 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
5,437——0Apr 1, 2026Apr 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
3,383$6.57$22.2K8,820Apr 1, 2026Apr 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
2,000——3,383Mar 2, 2026Mar 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
5,433$4.11$22.3K5,433Mar 2, 2026Mar 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
2,000$6.57$13.1K7,433Mar 2, 2026Mar 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
5,433——5,437Mar 2, 2026Mar 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
7,433$20.30$150.9K0Mar 2, 2026Mar 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
110,000——110,000Feb 17, 2026Feb 19, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
7,433$18.75$139.4K0Feb 2, 2026Feb 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
2,000——5,383Feb 2, 2026Feb 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
5,433——10,870Feb 2, 2026Feb 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
5,433$4.11$22.3K5,433Feb 2, 2026Feb 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
2,000$6.57$13.1K7,433Feb 2, 2026Feb 3, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
2,000$6.57$13.1K7,433Jan 2, 2026Jan 6, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
2,000——7,383Jan 2, 2026Jan 6, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
5,433——16,303Jan 2, 2026Jan 6, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
7,433$12.85$95.5K0Jan 2, 2026Jan 6, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
5,433$4.11$22.3K5,433Jan 2, 2026Jan 6, 2026 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
18,000$6.57$118.3K18,000Dec 9, 2025Dec 11, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
18,000$12.00$216.0K0Dec 9, 2025Dec 11, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
18,000——9,383Dec 9, 2025Dec 11, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASE
Chief Medical Officer
68,897$4.11$283.2K68,897Dec 4, 2025Dec 5, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
SALE10b5-1
10b5-1 plan
68,897$10.19$701.9K0Dec 4, 2025Dec 5, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
SALE
Chief Medical Officer
68,897——21,736Dec 4, 2025Dec 5, 2025 ↗View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Feb 18, 2025Feb 20, 2025 ↗View →
Other insiders · BIOA
Loading peer insiders…
About this filer
CIK 0001210905
ROLE
Chief Medical Officer
PRIMARY
BIOA
COMPANIES
1
ACTIVE SINCE
Feb 2025
MARKETPEEL · /INSIDER/0001210905DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback